Dosing of all patients was completed at the end of February No Serious Adverse Events (SAE’s) have been reported Phase 1 clinical...
GSAC Engineering Marks the First Phase of a Turnaround Plan to Drive its Corporate Growth StrategySTUART, Fla., March 07, 2023...
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines...
Dynamic Digital Radiography Dynamic Digital Radiography is an enhanced X-ray technology that enables clinicians to analyze and quantify the dynamic...
Pet Supermarket will Offer Halo Brand in 75 Retail Stores in the USA Halo Products Now Offered in 1500+ Retail...
One of the Fastest Growing Companies in Washington, DC, and Baltimore, Rebrands and Reaffirms Commitment To Helping Solve Complex Global...
LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty...
Treatments are comfortable, highly effective and with a fast recovery Patient undergoing gingival recontouring laser treatment with Spectralase at Smile...
The Industry’s Only SaaS Solution for the Coordination of Multiple Concurrent Patient Engagement Initiatives to Optimize Impact and EfficiencyBOWIE, Md.,...
Philips Intracardiac Echocardiography Catheter – VeriSight Pro Intravascular ultrasound (IVUS) catheter CIED infection March 6, 2023 Preliminary results of large-scale...
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the...
Year marked by noteworthy operational execution and clinical development progress across pipeline Company reiterates commitment to continued communication and activity...
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi,...
Live conference call on Friday, March 10 at 8:30 a.m. ETMIAMI, March 06, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:...
MINNEAPOLIS, March 06, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic...
WARREN, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report...
Figure 1 Fluoresceine angiogram data from three animals treated with NM3086 (bottom) and three that received placebo control. The picture...
Lorundrostat demonstrated clinically meaningful blood pressure reduction in individuals with uncontrolled hypertension Obesity was predictive of an enhanced response to...
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG regardless...